Molecular docking studies on COVID-19 and antibacterial evaluation of newly synthesized 4-(methoxymethyl)-1,2,3-triazolean analogues derived from (E)-1-phenyl-3-(2-(piperidin-1-yl)quinolin-3-yl) prop-2-en-1-one
Crossref DOI link: https://doi.org/10.1007/s13738-021-02365-y
Published Online: 2021-08-17
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nagamani, M.
Vishnu, T.
Jalapathi, P. https://orcid.org/0000-0002-5419-6868
Srinivas, M.
Text and Data Mining valid from 2021-08-17
Version of Record valid from 2021-08-17
Article History
Received: 2 January 2021
Accepted: 27 July 2021
First Online: 17 August 2021
Free to read: This content has been made available to all.